Stents formed from dissimilar metals for tissue growth control

Patent metadata

Field	Value
Publication number	US-10617540-B2
Application number	US-201715808583-A
Country	US
Kind code	B2
Filing date	Nov 9, 2017
Priority date	Nov 10, 2016
Publication date	Apr 14, 2020
Grant date	Apr 14, 2020

Abstract

Stents formed from dissimilar materials configured to control tissue growth. A stent may be formed from a composite wire helically wound into a stent having a tubular configuration. The composite wire includes a first wire and a second wire coupled together, the first and second wires being formed from dissimilar metals such that a potential difference is formed when the dissimilar metals are exposed to bodily fluids. The potential difference is configured to inhibit cell proliferation and thereby control tissue growth around the stent after implantation. A stent may be formed from a hollow composite wire including an inner member that includes first and second longitudinal strips formed from dissimilar metals. A stent may be formed from a composite wire having a plurality of windows along a length of the composite wire. An insert formed from a dissimilar metal is disposed within each window of the plurality of windows.

First claim

What is claimed is:

1. A stent configured to control tissue growth, the stent comprising:
a composite wire helically wound into a tubular configuration, wherein the composite wire is formed from a first wire and a second wire nested within each other in a circumferential direction and coupled together only at distinct fusion points, the first wire being shaped into a first sinusoidal waveform including a plurality of straight segments and a plurality of bent segments and the second wire being shaped into a second sinusoidal waveform including a plurality of straight segments and a plurality of bent segments, the bent and straight segments of the second sinusoidal waveform to fit within the bent and straight segments of the first sinusoidal waveform such that the second waveform is nested in the circumferential direction within the first waveform, and
wherein the first and second wires are formed from dissimilar metals such that a potential difference is formed when the dissimilar metals are exposed to bodily fluids, the potential difference being configured to inhibit cell proliferation and thereby control tissue growth around the stent after implantation.

2. The stent of claim 1 , wherein at least some of the bends of the first sinusoidal waveform are fused to at least some of the bends of the second sinusoidal waveform forming the fusion points.

3. The stent of claim 2 , wherein at least some of the straight segments of the first sinusoidal waveform are not fused to at least some of the straight segments of the second sinusoidal waveform.

4. The stent of claim 1 , wherein the composite wire further includes a third wire coupled to the first wire, the third wire being formed from a dissimilar metal from the first wire such that a potential difference is formed between the first and third wires when the first and third wires are exposed to bodily fluids, and wherein the third wire is shaped into a third sinusoidal waveform including a plurality of straight segments and a plurality of bent segments, the bent and straight segments of the first sinusoidal waveform fit within the bent and straight segments of the third sinusoidal waveform such that the first sinusoidal waveform is nested in the circumferential direction within the third sinusoidal waveform.

5. The stent of claim 4 , wherein the first wire is formed from a material selected from tantalum, tungsten, platinum, a platinum-iridium alloy, and gold and each of the second wire and the third wire is formed from a material selected from a cobalt-chromium alloy, magnesium, a magnesium alloy, and zinc.

6. The stent of claim 5 , wherein the second wire and the third wire are formed from the same material.

7. The stent of claim 5 , wherein the second wire and the third wire are formed from different materials.

8. The stent of claim 5 , wherein each of the first, second, and third wires has a circular cross-section.

9. The stent of claim 5 , wherein each of the first, second, and third wires is the same size.

10. The stent of claim 1 , wherein the first wire is formed from a material selected from tantalum, tungsten, platinum, a platinum-iridium alloy, and gold and the second wire is formed from a material selected from a cobalt-chromium alloy, magnesium, a magnesium alloy, and zinc.

11. The stent of claim 1 , wherein each of the first and second wires has a circular cross-section.

12. The stent of claim 1 , wherein each of the first and second wires is the same size.

13. A stent configured to control tissue growth, the stent comprising:
a composite wire helically wound into a tubular configuration, the composite wire being formed from a first wire, a second wire, and a third wire nested within each other, wherein
the first wire is shaped into a first sinusoidal waveform including a plurality of straight segments and a plurality of bent segments,
the second wire is shaped into a second sinusoidal waveform including a plurality of straight segments and a plurality of bent segments, the bent and straight segments of the second sinusoidal waveform to fit within the bent and straight segments of the first sinusoidal waveform such that the second waveform is configured to nested within the first waveform, and
the third wire is shaped into a third sinusoidal waveform including a plurality of straight segments and a plurality of bent segments, the bent and straight segments of the first sinusoidal waveform fit within the bent and straight segments of the third sinusoidal waveform such that the first sinusoidal waveform is nested within the third sinusoidal waveform to nest within the first waveform, and the first wire, the second wire, and the third wire are directly beside each other and only coupled to each other at distinct points in a circumferential direction with the first wire disposed between the second and third wires, and

wherein each of the second and third wire is formed from a dissimilar metal than the first wire such that a potential difference is formed when the dissimilar metals are exposed to bodily fluids, the potential difference being configured to inhibit cell proliferation and thereby control tissue growth around the stent after implantation.

14. The stent of claim 13 , wherein at least some of the bends of the first sinusoidal waveform are fused to at least some of the bends of each of the second and third sinusoidal waveforms.

15. The stent of claim 14 , wherein at least some of the straight segments of the first sinusoidal waveform are not fused to at least some of the straight segments of each of the second and third sinusoidal waveforms.

16. The stent of claim 13 , wherein the first wire is formed from a material selected from tantalum, tungsten, platinum, a platinum-iridium alloy, and gold and each of the second wire and the third wire is formed from a material selected from a cobalt-chromium alloy, magnesium, a magnesium alloy, and zinc.

17. The stent of claim 16 , wherein the second wire and the third wire are formed from the same material.

18. The stent of claim 16 , wherein the second wire and the third wire are formed from different materials.

19. The stent of claim 13 , wherein each of the first, second, and third wires has a circular cross-section.

20. The stent of claim 13 , wherein each of the first, second, and third wires is the same size.

Assignees

• Medtronic Vascular Inc

Inventors

• Peterson Justin
• Bienvenu Ryan
• Tunev Stefan
• Harms Michael

Classifications

• A61L31/16

  Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

• A61F2250/0054

  differing in corrosion resistance · CPC title

• A61F2250/0015

  differing in density or specific weight · CPC title

• A61F2/90 Primary

  characterised by a net-like or mesh-like structure · CPC title

• A61F2210/0076

  multilayered, e.g. laminated structures · CPC title